Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Sicit Group S P A has 1 pending office action. This action is assigned to 1 distinct examiner, BOECKELMAN, JACOB A, who is the busiest examiner with 1 pending office action. There are 0 distinct art units listed for this portfolio, which may indicate the application is in an early stage or has a unique classification. The company's current prosecution is focused on a single matter with BOECKELMAN, JACOB A. This centralized activity means the company's immediate patent goals depend entirely on the outcome of this one interaction.
Practitioners should focus on the specific feedback from BOECKELMAN, JACOB A to move the application forward. The lack of other pending actions or art units simplifies the current strategic requirements for this company. Future filings may expand this footprint, but the current data shows a singular focus on one pending matter with a single examiner. This profile represents a very targeted approach to patent acquisition, where the primary goal is to satisfy the requirements of a single examiner. The lack of art unit data places even more emphasis on the individual examiner involved.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOECKELMAN, JACOB A | 1 | 34.9% | +46.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18850406 | PROCESS FOR THE PREPARATION OF A HYDROLYZED EXTRACT OF NON-ANIMAL ORIGIN | BOECKELMAN, JACOB A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18850406 | PROCESS FOR THE PREPARATION OF A HYDROLYZED EXTRACT OF NON-ANIMAL ORIGIN | BOECKELMAN, JACOB A | — |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18850406 | PROCESS FOR THE PREPARATION OF A HYDROLYZED EXTRACT OF NON-ANIMAL ORIGIN | BOECKELMAN, JACOB A | 1655 | §103§112 | Non-Final OA | — | Pending | Sep 24, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSicit Group S P A has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jacob A Boeckelman has the most, with 1 of Sicit Group S P A's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.